Print Print
CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.

Palliative cancer care - cough - Management
What general information about pholcodine should I be aware of?

  • If the person is already taking a strong opioid such as morphine, do not try a weak opioid such as pholcodine. Instead an 'as required' dose of morphine solution should be used to relieve cough and, if this is beneficial, continue to use in this way, or increase the regular morphine dose [Twycross et al, 2002]. The 'as required' dose is a sixth of the total daily dose of regular morphine.
  • Pholcodine Linctus BP 10 mg may be taken three to four times a day for symptomatic relief of unproductive coughs. Sugar-free brands are available where preferred, and for people with diabetes.
  • The adverse effects usually associated with opioids (e.g. constipation) are rarely reported, as pholcodine is such a weak opioid. However, it has mild sedative properties and so people should be warned to avoid activities where drowsiness may be detrimental.
  • If pholcodine (or codeine) is ineffective, switch to morphine solution 5 mg to 10 mg every 4 hours and 'as required'.

[ABPI Medicines Compendium, 2003; BNF 53, 2007]

© NHS Institute for Innovation and Improvement